![](https://www.malaymail.com/theme_malaymail/images/malaymail/og-image.png)
Zuellig Pharma enters into an agreement with Regeneron to bring Libtayo® (cemiplimab) to South Korea and Taiwan markets
SINGAPORE - Media OutReach Newswire - 28 August 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced an exclusive distribution agreement with Regeneron Ireland DAC, a wholly owned subsidiary of Regeneron Pharmaceuticals, Inc …